Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

SEMI-DISPOSABLE INSULIN PATCH PUMP: THE BEST SOLUTION FOR DIABETES PATIENTS

Project description

Innovative microfluidic device improves diabetes management

Millions of patients in Europe with type I diabetes have a lifetime dependency on insulin. Therefore, there is a need for comfortable, easy-to-use and cheap medical devices for measuring glucose levels and delivering insulin on a daily basis. The EU-funded DiAMS project has developed an innovative device that combines a patch pump, a continuous glucose monitoring system and a management interface which can be controlled through a smartphone. The insulin patch pump is semi-disposable and employs microfluidics technology, rendering it safer for use in hospitals and at home. Importantly, the technology can be expanded to deliver other drugs in the future.

Objective

Diabetes is the second more frequent disease in the world with around 422 M cases and about 12% of global health expenditure. Many patients, mostly with type I diabetes, depend on insulin delivery to have a high-quality life and need comfortable, wearable, easy to use and cheap medical devices. In Europe, about 60 M people have diabetes and more than 71 M are estimated by 2040. Around 6 M Europeans have type I diabetes from which about 140.000 are children (the highest world prevalence), making it an European health prority.AMF develops, manufactures and sells microfluidics components for high performance applications. We aim to offering a new solution for insulin treatment for diabetes patients and we have developed a microfluidic technology to serve as a basis for our semi-disposable insulin patch-pump. The use of our intelligent, compact and cost-effective DiAMS will disrupt the field of insulin delivery and make it a safer, more reliable and more mobile for care in hospitals and at home solution. Our system is practically invisible, composed of a patch pump, a continuos glucose monitoring (CGM) and a management interface through a LiNK component that can be controlled through the smartphone. The business opportunities are tremendous because today only Insulet Corporation and Roche offer a product on the patch-pump market, which despite its moderate success have opened the door and let us strongly compete in it thanks to our partially disposable concept and the use if orefilled insulin cartridges. Our technology has many potential applications in drug delivery in the future. DiAMS takes into account the European challenges by making the insulin treatment easier, cheaper, more accurate and more comfortable to patients. In phase 1 we plan to build a detailed feasibility study and business plan to establish the needs for DiAMS commercialization. We estimate a €3.5M funding for phase 2 and potential profits of €59 M after 5 years.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

AMF MEDICAL SA
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
CHEMIN DE LA DENT D'OCHE 1A
1024 ECUBLENS VD
Switzerland

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Schweiz/Suisse/Svizzera Région lémanique Vaud
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0